FI890603A - Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi - Google Patents

Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi Download PDF

Info

Publication number
FI890603A
FI890603A FI890603A FI890603A FI890603A FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A
Authority
FI
Finland
Prior art keywords
immunogen
hiv
retrovirus
infectious
useful
Prior art date
Application number
FI890603A
Other languages
English (en)
Swedish (sv)
Other versions
FI95871C (fi
FI890603A0 (fi
FI95871B (fi
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of FI890603A publication Critical patent/FI890603A/fi
Publication of FI890603A0 publication Critical patent/FI890603A0/fi
Application granted granted Critical
Publication of FI95871B publication Critical patent/FI95871B/fi
Publication of FI95871C publication Critical patent/FI95871C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
FI890603A 1987-06-10 1989-02-08 Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi FI95871C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US6028087 1987-06-10
US20075288A 1988-05-31 1988-05-31
US20075288 1988-05-31
US8801955 1988-06-09
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease

Publications (4)

Publication Number Publication Date
FI890603A true FI890603A (fi) 1989-02-08
FI890603A0 FI890603A0 (fi) 1989-02-08
FI95871B FI95871B (fi) 1995-12-29
FI95871C FI95871C (fi) 1996-04-10

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890603A FI95871C (fi) 1987-06-10 1989-02-08 Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi

Country Status (14)

Country Link
EP (3) EP0602761A1 (fi)
JP (1) JPH0720880B2 (fi)
AT (1) ATE132374T1 (fi)
AU (1) AU612383B2 (fi)
CA (1) CA1336407C (fi)
DE (1) DE3854857T2 (fi)
DK (1) DK56389D0 (fi)
FI (1) FI95871C (fi)
IL (1) IL86675A (fi)
NO (1) NO175846C (fi)
OA (1) OA09037A (fi)
RU (1) RU2111010C1 (fi)
UA (1) UA27716C2 (fi)
WO (1) WO1988009670A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287226A1 (en) * 1987-03-23 1988-10-19 Hiver Limited Novel vaccines
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ES2141929T3 (es) * 1994-03-22 2000-04-01 Immune Response Corp Inc Produccion y aislamiento muy eficientes de particulas viricas.
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
EP0187041B1 (en) * 1984-12-24 1996-05-15 Genentech, Inc. Fusions of AIDS-related polypeptides
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
EP0249611A4 (en) * 1985-11-14 1988-04-26 Harvard College T-LYMPHOTROPHIC VIRUS.
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen

Also Published As

Publication number Publication date
JPH02500440A (ja) 1990-02-15
DE3854857D1 (de) 1996-02-15
DK56389A (da) 1989-02-08
NO175846B (fi) 1994-09-12
CA1336407C (en) 1995-07-25
FI95871C (fi) 1996-04-10
ATE132374T1 (de) 1996-01-15
AU612383B2 (en) 1991-07-11
FI890603A0 (fi) 1989-02-08
OA09037A (en) 1991-03-31
JPH0720880B2 (ja) 1995-03-08
AU1962688A (en) 1989-01-04
UA27716C2 (uk) 2000-10-16
EP0602761A1 (en) 1994-06-22
EP0317622A1 (en) 1989-05-31
EP0317622A4 (en) 1990-05-14
DE3854857T2 (de) 1996-08-22
NO890565D0 (no) 1989-02-09
EP0685236A1 (en) 1995-12-06
FI95871B (fi) 1995-12-29
NO890565L (no) 1989-02-09
NO175846C (no) 1994-12-21
IL86675A (en) 1993-04-04
EP0317622B1 (en) 1996-01-03
WO1988009670A1 (en) 1988-12-15
RU2111010C1 (ru) 1998-05-20
DK56389D0 (da) 1989-02-08

Similar Documents

Publication Publication Date Title
DE69535075D1 (de) Antigen-markierte nicht-infektiöse retrovirus-ähnlige partikel
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
GR3019112T3 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic.
FI842215A (fi) Foerfarande foer framstaellning av levande effektiveringsvaccin och pao detta saett erhaollna vaccin.
FI890603A0 (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
SE8701765L (sv) Analysmetod och medel foer denna
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
EP0513371A4 (en) Human parainfluenza virus type 4a fusion protein and gene which codes for the same
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
WO1991008771A3 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
AU6791290A (en) Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or
TH45965A3 (th) วิธีการสำหรับการเหนี่ยวนำภูมิคุ้มกันต่อไวรัส

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE IMMUNE RESPONSE CORPORATION, INC.

MA Patent expired